Stem Cell Protection Against Inflammation Using Chemical Formula 1

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods are insufficient in restoring damaged stemness and inhibiting inflammation or aging of mesenchymal stem cells, particularly due to mitochondrial dysfunction and exposure to pro-inflammatory cytokines, which affects their utility in regenerative medicine and tissue engineering.

Innovation Solution

A composition comprising a compound of Chemical Formula 1 or its pharmaceutically acceptable salt is used to treat stem cells, protecting them from inflammatory environments, restoring mitochondrial function, and maintaining stemness, thereby inhibiting inflammation and aging.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If stem cells are exposed to pro-inflammatory cytokines in vivo, then they can be used for tissue regeneration, but mitochondrial dysfunction and aging occur

Engineering Contradiction:
Improvestem cell functionalityVSAvoidmitochondrial dysfunction
Core Design Contradiction:
ReliabilityVSObject-affected harmful factors

Solution Approach 1:

The compound of Chemical Formula 1 is administered to stem cells before they undergo mitochondrial dysfunction or aging induced by pro-inflammatory cytokines. This preliminary protective action prevents the harmful effects from occurring, maintaining mitochondrial function and stem cell viability while still allowing the cells to perform their regenerative function in the inflammatory environment.

Inventive Principle:
Principle #9Preliminary anti-action

Solution Approach 2:

The compound of Chemical Formula 1 acts as an intermediary substance between the pro-inflammatory cytokines and the stem cells. It mediates the interaction by blocking the harmful signaling pathways that lead to mitochondrial dysfunction, thereby protecting stem cells from the inflammatory environment while preserving their therapeutic potential.

Inventive Principle:
Principle #24Intermediary (Mediator)

2Reliability

If conventional methods are used to restore damaged stemness, then treatment can be provided, but the methods are insufficient in restoring damaged stemness and inhibiting inflammation

Engineering Contradiction:
Improvestemness restorationVSAvoidstemness restoration efficacy
Core Design Contradiction:
ReliabilityVSManufacturing precision

Solution Approach 1:

The compound of Chemical Formula 1 changes key parameters related to stem cell function, including mitochondrial membrane potential, ATP production, and expression of stemness markers. By modifying these critical parameters, the compound effectively restores damaged stemness and inhibits inflammation, overcoming the limitations of conventional methods.

Inventive Principle:
Principle #35Parameter changes

Data Source

PatentUS20240374646A1Composition for inhibiting inflammation or aging of stem cells, and method for inhibiting inflammation or aging by using same
Publication Date: 2024.11.14 MITOIMMUNE THERAPEUTICS INC
  • US20240374646A1 patent drawing
  • US20240374646A1 patent drawing
  • US20240374646A1 patent drawing

AI summary

The present invention relates to a composition for inhibiting the inflammation or aging of stem cells, comprising, as an active ingredient, a compound of Chemical Formula 1 or a pharmaceutically acceptable salt thereof; a method for inhibiting the inflammation or aging of stem cells by using the same; and a method for preparing stem cells having inhibited inflammation or aging; and a pharmaceutical composition for preventing or treating inflammatory diseases, comprising the stem cells, wherein when stem cells are treated with the compound of Chemical Formula 1, the inflammation or aging of stem cells can be inhibited so that the function and morphology of stem cells and intracellular mitochondria damaged in an inflammatory environment can be restored, and the stem cells treated with the compound of Chemical Formula 1 can be effectively used in the prevention or treatment of inflammatory diseases.